QI
GRTS

QS Investors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

QS Investors’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$372K Buy
+40,700
New +$376K ﹤0.01% 854

Other funds holding GRTS

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

QS Investors's GRTS Position: Q2 2021 in Review

QS Investors opened a new position in Gritstone bio, Inc. Common Stock (GRTS) in Q2 2021: 40,700 shares worth $372K. The stake represents ﹤0.01% of the portfolio and ranks #854 among its holdings.

102 funds tracked by Wall St. Rank hold GRTS as of Q2 2021.

  • QS Investors held 40,700 shares of Gritstone bio, Inc. Common Stock worth $372K as of Q2 2021.
  • Gritstone bio, Inc. Common Stock was a new QS Investors position in Q2 2021.
  • Gritstone bio, Inc. Common Stock made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #854 holding.
  • 102 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.